BCAT1 and B-cell chronic lymphocytic leukemia: BCAT1-driven catabolism has been linked to enhanced growth: for instance, chronic lymphocytic leukemia cells are “avid consumers” of BCAAs, using BCAT1 bidirectionally to both degrade BCAAs and regenerate them as needed [26].